These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31658979)

  • 21. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.
    Helb DA; Tetteh KK; Felgner PL; Skinner J; Hubbard A; Arinaitwe E; Mayanja-Kizza H; Ssewanyana I; Kamya MR; Beeson JG; Tappero J; Smith DL; Crompton PD; Rosenthal PJ; Dorsey G; Drakeley CJ; Greenhouse B
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4438-47. PubMed ID: 26216993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.
    Ahmed Ismail H; Tijani MK; Langer C; Reiling L; White MT; Beeson JG; Wahlgren M; Nwuba R; Persson KE
    Malar J; 2014 Nov; 13():425. PubMed ID: 25373511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
    Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
    Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.
    Sakamoto H; Takeo S; Takashima E; Miura K; Kanoi BN; Kaneko T; Han ET; Tachibana M; Matsuoka K; Sattabongkot J; Udomsangpetch R; Ishino T; Tsuboi T
    Parasitol Int; 2018 Apr; 67(2):203-208. PubMed ID: 29217416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure.
    Kessler A; Campo JJ; Harawa V; Mandala WL; Rogerson SJ; Mowrey WB; Seydel KB; Kim K
    Malar J; 2018 Apr; 17(1):178. PubMed ID: 29695240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.
    Chan JA; Howell KB; Reiling L; Ataide R; Mackintosh CL; Fowkes FJ; Petter M; Chesson JM; Langer C; Warimwe GM; Duffy MF; Rogerson SJ; Bull PC; Cowman AF; Marsh K; Beeson JG
    J Clin Invest; 2012 Sep; 122(9):3227-38. PubMed ID: 22850879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
    Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
    Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ; Richards JS; Simpson JA; Beeson JG
    PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens.
    Ofori MF; Dodoo D; Staalsoe T; Kurtzhals JA; Koram K; Theander TG; Akanmori BD; Hviid L
    Infect Immun; 2002 Jun; 70(6):2982-8. PubMed ID: 12010988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria.
    Azcárate IG; Marín-García P; Abad P; Pérez-Benavente S; Paz-Artal E; Reche PA; Fobil JN; Rubio JM; Diez A; Puyet A; Bautista JM
    Sci Rep; 2020 Jun; 10(1):9398. PubMed ID: 32523082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
    McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
    Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C
    PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein (TRAP) of Plasmodium falciparum in naturally infected patients from unstable malaria areas in Iran.
    Pirahmadi S; Zakeri S; Mehrizi AA; Karimi L; Djadid ND
    Acta Trop; 2019 Feb; 190():365-374. PubMed ID: 30543766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenicity and immune correlate assessment of seven Plasmodium falciparum antigens in a longitudinal infant cohort from northern Ghana.
    Kusi KA; Aguiar J; Kumordjie S; Aggor F; Bolton J; Renner A; Kyei-Baafour E; Puplampu N; Belmonte M; Dodoo D; Gyan BA; Ofori MF; Oduro AR; Atuguba F; Koram KA; Adams N; Letizia A; Villasante E; Sedegah M
    Sci Rep; 2019 Jun; 9(1):8621. PubMed ID: 31197225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.
    Riley EM; Allen SJ; Wheeler JG; Blackman MJ; Bennett S; Takacs B; Schönfeld HJ; Holder AA; Greenwood BM
    Parasite Immunol; 1992 May; 14(3):321-37. PubMed ID: 1625908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants.
    Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP
    Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
    Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
    Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Antigens Derived from
    Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.